REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07218770 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2028-06-28 → 2026-07-21 3. primary completion date: 2028-06-28 → 2026-07-21 4. enrollment: 72 → 1 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical